Reshma Ramachandran

1.3k total citations
76 papers, 799 citations indexed

About

Reshma Ramachandran is a scholar working on Economics and Econometrics, Pharmacology and Food Science. According to data from OpenAlex, Reshma Ramachandran has authored 76 papers receiving a total of 799 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Economics and Econometrics, 11 papers in Pharmacology and 11 papers in Food Science. Recurrent topics in Reshma Ramachandran's work include Health Systems, Economic Evaluations, Quality of Life (25 papers), Pharmaceutical Economics and Policy (23 papers) and Salmonella and Campylobacter epidemiology (11 papers). Reshma Ramachandran is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (25 papers), Pharmaceutical Economics and Policy (23 papers) and Salmonella and Campylobacter epidemiology (11 papers). Reshma Ramachandran collaborates with scholars based in United States, India and Egypt. Reshma Ramachandran's co-authors include Enrique Escalon, Priyanka Nair, Steven J. Melnick, Cheppail Ramachandran, Joseph S. Ross, Sonia Rodrı́guez, Joshua D. Wallach, Hugo B. Fonseca, Ziad Khatib and Stanislaw F. Wnuk and has published in prestigious journals such as New England Journal of Medicine, JAMA and Nature Medicine.

In The Last Decade

Reshma Ramachandran

62 papers receiving 776 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Reshma Ramachandran United States 13 196 125 117 109 104 76 799
Godfrey S. Bbosa Uganda 11 88 0.4× 40 0.3× 315 2.7× 81 0.7× 91 0.9× 39 781
Noor Rain Abdullah Malaysia 14 231 1.2× 36 0.3× 270 2.3× 215 2.0× 49 0.5× 29 824
Lígia Carla Faccin‐Galhardi Brazil 17 206 1.1× 16 0.1× 256 2.2× 87 0.8× 108 1.0× 41 853
Hisham N. Altayb Saudi Arabia 18 303 1.5× 15 0.1× 98 0.8× 44 0.4× 124 1.2× 92 937
Wataru Watanabe Japan 23 481 2.5× 25 0.2× 163 1.4× 74 0.7× 224 2.2× 49 1.7k
Alex Boye Ghana 16 200 1.0× 20 0.2× 94 0.8× 50 0.5× 65 0.6× 62 658
Jean-Baptiste Nikiéma Burkina Faso 12 107 0.5× 34 0.3× 165 1.4× 61 0.6× 132 1.3× 22 607
Dharmendra Kumar India 12 104 0.5× 22 0.2× 121 1.0× 82 0.8× 130 1.3× 31 558
Omnia Kutkat Egypt 19 316 1.6× 6 0.0× 75 0.6× 105 1.0× 115 1.1× 64 1.2k
Said Gonçalves da Cruz Fonseca Brazil 17 222 1.1× 12 0.1× 320 2.7× 93 0.9× 411 4.0× 49 1.1k

Countries citing papers authored by Reshma Ramachandran

Since Specialization
Citations

This map shows the geographic impact of Reshma Ramachandran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reshma Ramachandran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reshma Ramachandran more than expected).

Fields of papers citing papers by Reshma Ramachandran

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Reshma Ramachandran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reshma Ramachandran. The network helps show where Reshma Ramachandran may publish in the future.

Co-authorship network of co-authors of Reshma Ramachandran

This figure shows the co-authorship network connecting the top 25 collaborators of Reshma Ramachandran. A scholar is included among the top collaborators of Reshma Ramachandran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Reshma Ramachandran. Reshma Ramachandran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ramachandran, Reshma, et al.. (2025). Online Advertising of Compounded Glucagon-Like Peptide-1 Receptor Agonists. JAMA Health Forum. 6(1). e245018–e245018. 4 indexed citations
2.
3.
4.
Ramachandran, Reshma, Anuraj T. Sukumaran, A.S. Kiess, et al.. (2024). Research Note: Evaluating the vertical transmission potential of Salmonella Reading in broiler breeders. Poultry Science. 103(12). 104351–104351. 2 indexed citations
5.
Qureshi, Omar, Reshma Ramachandran, & Joseph S. Ross. (2024). Medicare Part B and Part D drug eligibility for center for Medicare and Medicaid Services price negotiation under the Inflation Reduction Act: estimates using 2016–2019 data. Journal of Pharmaceutical Policy and Practice. 17(1). 2312374–2312374. 1 indexed citations
6.
Ramachandran, Reshma, et al.. (2024). Trans-Cinnamaldehyde Primes More Robust Channel Catfish Immune Responses to Edwardsiella ictaluri Infection. Pathogens. 13(4). 310–310. 1 indexed citations
7.
Ramachandran, Reshma, et al.. (2024). Consent Form Reporting on ClinicalTrials.Gov, 2013-2023. JAMA Network Open. 7(6). e2418895–e2418895. 1 indexed citations
8.
9.
Ramachandran, Reshma, et al.. (2024). Lessons From Insulin: Policy Prescriptions for Affordable Diabetes and Obesity Medications. Diabetes Care. 47(8). 1246–1256. 7 indexed citations
10.
Miller, Jennifer, Sakinah C. Suttiratana, Michael O. Mensah, et al.. (2024). Harnessing policy to promote inclusive medical product evidence: development of a reference standard and structured audit of clinical trial diversity policies. SHILAP Revista de lepidopterología. 3(1). e000920–e000920. 2 indexed citations
11.
Ross, Joseph S., et al.. (2024). Implications for Public Health Regulation if Chevron Deference Is Overturned. JAMA. 331(17). 1443–1443. 3 indexed citations
12.
Ross, Joseph S., et al.. (2024). Premarket Pivotal Trial End Points and Postmarketing Requirements for FDA Breakthrough Therapies. JAMA Network Open. 7(8). e2430486–e2430486. 2 indexed citations
13.
14.
Barbieri, Nicolle L., et al.. (2023). Characterization of Avian Pathogenic Escherichia coli Isolated from Broiler Breeders with Colibacillosis in Mississippi. SHILAP Revista de lepidopterología. 2(1). 24–39. 10 indexed citations
15.
Dhodapkar, Meera M., Joseph S. Ross, & Reshma Ramachandran. (2023). US Food and Drug Administration Review Time of Supplemental New Indication Approvals of Drugs and Biologics, 2017 to 2019. JAMA Network Open. 6(6). e2318889–e2318889. 1 indexed citations
16.
Glick, Laura, et al.. (2023). Financial conflicts of interest among US physician authors of 2020 clinical practice guidelines: a cross-sectional study. BMJ Open. 13(1). e069115–e069115. 12 indexed citations
17.
18.
Wallach, Joshua D., et al.. (2023). Clinical practice guideline descriptions of oncologic drugs granted FDA accelerated approval: A cross-sectional study.. Journal of Clinical Oncology. 41(16_suppl). 1590–1590. 2 indexed citations
19.
Ramachandran, Reshma, et al.. (2023). Use of Expedited Regulatory Programs and Clinical Development Times for FDA-Approved Novel Therapeutics. JAMA Network Open. 6(8). e2331753–e2331753. 7 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Godfrey S. Bbosa Breakdown of academic impact, for papers by Noor Rain Abdullah Breakdown of academic impact, for papers by Lígia Carla Faccin‐Galhardi Breakdown of academic impact, for papers by Hisham N. Altayb Breakdown of academic impact, for papers by Wataru Watanabe Breakdown of academic impact, for papers by Alex Boye Breakdown of academic impact, for papers by Jean-Baptiste Nikiéma Breakdown of academic impact, for papers by Dharmendra Kumar Breakdown of academic impact, for papers by Omnia Kutkat Breakdown of academic impact, for papers by Said Gonçalves da Cruz Fonseca
Rankless by CCL
2026